Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/21138476
Conclusion of this study
We conclude that melatonin therapy may be of benefit for patients with MS, particularly with arterial hypertension. Further studies with higher doses of melatonin or prolonged supplementation are awaited.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study